![Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing's sarcoma A673-xenograft growth and normalize tumor vascular architecture | SpringerLink Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing's sarcoma A673-xenograft growth and normalize tumor vascular architecture | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10456-012-9294-9/MediaObjects/10456_2012_9294_Fig1_HTML.gif)
Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing's sarcoma A673-xenograft growth and normalize tumor vascular architecture | SpringerLink
Jakob, you are a great inspiration for many | Jakob afsluttede sin kræftbehandlingen for under en måned siden. I søndags 20 dage senere krydsede han målstregen til Copenhagen Marathon. Jakob blev...
![Palmitoylation inhibition mediated by the local anesthetics resulted in... | Download Scientific Diagram Palmitoylation inhibition mediated by the local anesthetics resulted in... | Download Scientific Diagram](https://www.researchgate.net/publication/349048867/figure/fig5/AS:987859129483264@1612535378427/Palmitoylation-inhibition-mediated-by-the-local-anesthetics-resulted-in-the-disappearance_Q320.jpg)
Palmitoylation inhibition mediated by the local anesthetics resulted in... | Download Scientific Diagram
![STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers | Life Science Alliance STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers | Life Science Alliance](https://www.life-science-alliance.org/content/lsa/3/7/e202000725/F3.large.jpg)
STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers | Life Science Alliance
![STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers | Life Science Alliance STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers | Life Science Alliance](https://www.life-science-alliance.org/content/lsa/3/7/e202000725/F1.large.jpg)
STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers | Life Science Alliance
![Parthasarathy Seshacharyulu, PhD | Department of Biochemistry and Molecular Biology | University of Nebraska Medical Center Parthasarathy Seshacharyulu, PhD | Department of Biochemistry and Molecular Biology | University of Nebraska Medical Center](https://www.unmc.edu/biochemistry/_images/research-images/seshacharyulu-image.png)
Parthasarathy Seshacharyulu, PhD | Department of Biochemistry and Molecular Biology | University of Nebraska Medical Center
![STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers | Life Science Alliance STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers | Life Science Alliance](https://www.life-science-alliance.org/sites/default/files/highwire/lsa/3/7.cover-source.jpg)